Walsh Jeffrey T. 4
4 · bluebird bio, Inc. · Filed Apr 12, 2019
Insider Transaction Report
Form 4
Walsh Jeffrey T.
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-04-10−1,500→ 13,021 totalExercise: $24.47Exp: 2024-03-03→ Common Stock (1,500 underlying) - Sale
Common Stock
2019-04-10$156.44/sh−1,100$172,085→ 41,321 total - Exercise/Conversion
Common Stock
2019-04-10$24.47/sh+1,500$36,705→ 42,421 total - Sale
Common Stock
2019-04-10$157.23/sh−400$62,891→ 40,921 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- [F2]The range of prices for the transaction reported on this line was $156.09 to $156.62. The average weighted price was $156.4409. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The range of prices for the transaction reported on this line was $157.09 to $157.38. The average weighted price was $157.2275. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.